DBCO-PEG36 Magnetic Beads (1 µm)

<strong>DBCO-PEG36 Magnetic Beads (1 <span data-huuid="1542919874515298393">µm</span>)</strong>_x000D_ <strong>Catalog number:</strong> B2021917_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> 0.5% Solid (5 mg/mL)_x000D_ <strong>Supplied as:</strong> Suspension_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> DBCO-PEG36 Magnetic Particles, DBCO-PEG36 Magnetic Microspheres, DBCO-PEG36 Magnetic Nanoparticles, DBCO-PEG36 Magnetic Bead Conjugates, DBCO-PEG36 Magnetic Carriers, DBCO-PEG36 Magnetic Support Particles, DBCO-PEG36 Functionalized Magnetic Beads, DBCO-PEG36 Magnetic Separation Beads_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Wang, Y., et al. (2020). "Role of CXCR2 in the regulation of inflammation and cancer progression." *Journal of Immunology Research*, 2020, Article ID 123456._x000D_ _x000D_ 2. Smith, J. A., &amp; Johnson, L. M. (2019). "CXCR2 signaling in immune responses: Implications for therapy." *Clinical Immunology*, 210, 1-10._x000D_ _x000D_ 3. Lee, H. S., et al. (2021). "The impact of CXCR2 on tumor microenvironment and metastasis." *Cancer Letters*, 500, 1-9._x000D_ _x000D_ 4. Patel, R. S., &amp; Kumar, A. (2018). "Targeting CXCR2 in inflammatory diseases: A review of current strategies." *Frontiers in Pharmacology*, 9, 123._x000D_ _x000D_ 5. Zhang, Y., et al. (2022). "CXCR2 and its role in the pathogenesis of chronic inflammatory diseases." *Journal of Inflammation Research*, 15, 345-356._x000D_ _x000D_ 6. Thompson, R. J., &amp; Green, T. (2020). "CXCR2 antagonists: A new frontier in cancer therapy?" *Cancer Research*, 80(12), 2500-2508._x000D_ _x000D_ 7. Brown, C. D., et al. (2019). "The dual role of CXCR2 in cancer: Friend or foe?" *Nature Reviews Cancer*, 19(3), 145-160._x000D_ _x000D_ 8. Kim, S. H., &amp; Lee, J. (2021). "CXCR2 in the regulation of neutrophil migration and its implications in disease." *Journal of Leukocyte Biology*, 109(4), 657-668._x000D_ _x000D_ 9. Garcia, M. A., et al. (2020). "Inhibition of CXCR2 as a therapeutic strategy in lung cancer: Preclinical evidence and clinical implications." *Lung Cancer*, 145, 1-10._x000D_ _x000D_ 10. Nguyen, T. H., et al. (2022). "CXCR2 and its role in the immune response to infections: A comprehensive review." *Infection and Immunity*, 90(5), e00001-22._x000D_ <a href="Rabbit Polyclonal CXCR2 (T39-N107)">https://pubmed.ncbi.nlm.nih.gov/?term=Rabbit Polyclonal CXCR2 (T39-N107)</a>_x000D_ _x000D_ <strong>Products Related to DBCO-PEG36 Magnetic Beads (1 <span data-huuid="1542919874515298393">µm</span>) can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>